Liminal BioSciences

+$0.0215 (+4.36%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LMNL and other ETFs, options, and stocks.

About LMNL

Liminal BioSciences, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using drug discovery platform and a data driven approach.

CEO
Bruce Philip Pritchard
Employees
48
Headquarters
Laval, Québec
Founded
1994

LMNL Key Statistics

Market cap
15.81M
Price-Earnings ratio
—
Dividend yield
—
Average volume
29.90K
High today
$0.5347
Low today
$0.485
Open price
$0.485
Volume
40.22K
52 Week high
$6.30
52 Week low
$0.3652

LMNL Earnings

-$1.25
-$0.83
-$0.42
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure